Cancer Treatment

How much does PSA need to drop to know that prostate cancer treatment is really working? A new study published today (Monday) in the journal CANCER of the American Cancer Society points to a clear target: a PSA level lower than 0.2 ng/mL within nine months of starting treatment was associated with better survival among patients with metastatic hormone-sensitive prostate cancer.

The biomed company of the former BrainsWay CEO, which developed a cancer treatment, will list its shares for trading on the local stock exchange as well. After a 300% jump in the last year, the company's shares are trading at a valuation of $1.2 billion.